Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HIV-1 protease-IN-9 (compound 5b), a potent HIV-1 protease inhibitor, exhibits strong antiviral efficacy with a dissociation constant (K_i) of 0.028 nM and a half-maximal inhibitory concentration (IC_50) of 66.8 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,370.00 | |
50 mg | Inquiry | $ 2,780.00 | |
100 mg | Inquiry | $ 3,700.00 |
Description | HIV-1 protease-IN-9 (compound 5b), a potent HIV-1 protease inhibitor, exhibits strong antiviral efficacy with a dissociation constant (K_i) of 0.028 nM and a half-maximal inhibitory concentration (IC_50) of 66.8 nM [1]. |
Molecular Weight | 679.83 |
Formula | C37H41N7O4S |
CAS No. | 2925381-27-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HIV-1 protease-IN-9 2925381-27-5 Microbiology/Virology Proteases/Proteasome HIV Protease inhibitor inhibit